Optomed Oyj Statistics

Total Valuation

Optomed Oyj has a market cap or net worth of EUR 81.62 million. The enterprise value is 74.39 million.

Market Cap	81.62M
Enterprise Value	74.39M

Important Dates

The next estimated earnings date is Thursday, February 13, 2025.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Optomed Oyj has 19.60 million shares outstanding. The number of shares has increased by 13.57% in one year.

Current Share Class	n/a
Shares Outstanding	19.60M
Shares Change (YoY)	+13.57%
Shares Change (QoQ)	+3.97%
Owned by Insiders (%)	0.50%
Owned by Institutions (%)	53.48%
Float	14.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.60
PB Ratio	3.30
P/TBV Ratio	4.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.42
EV / Sales	5.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-27.67

Financial Position

The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.15.

Current Ratio	3.29
Quick Ratio	2.76
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	-1.39
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.83% and return on invested capital (ROIC) is -12.88%.

Return on Equity (ROE)	-25.83%
Return on Assets (ROA)	-11.29%
Return on Capital (ROIC)	-12.88%
Revenue Per Employee	120,363
Profits Per Employee	-53,009
Employee Count	114
Asset Turnover	0.43
Inventory Turnover	1.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.21% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+30.21%
50-Day Moving Average	4.19
200-Day Moving Average	4.99
Relative Strength Index (RSI)	45.00
Average Volume (20 Days)	38,768

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Optomed Oyj had revenue of EUR 13.60 million and -5.99 million in losses. Loss per share was -0.33.

Revenue	13.60M
Gross Profit	8.81M
Operating Income	-5.76M
Pretax Income	-6.06M
Net Income	-5.99M
EBITDA	-4.83M
EBIT	-5.76M
Loss Per Share	-0.33

Full Income Statement

Balance Sheet

The company has 10.96 million in cash and 3.73 million in debt, giving a net cash position of 7.23 million or 0.37 per share.

Cash & Cash Equivalents	10.96M
Total Debt	3.73M
Net Cash	7.23M
Net Cash Per Share	0.37
Equity (Book Value)	24.70M
Book Value Per Share	1.26
Working Capital	11.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.50 million and capital expenditures -187,000, giving a free cash flow of -2.69 million.

Operating Cash Flow	-2.50M
Capital Expenditures	-187,000
Free Cash Flow	-2.69M
FCF Per Share	-0.14

Full Cash Flow Statement

Margins

Gross margin is 64.80%, with operating and profit margins of -42.33% and -44.04%.

Gross Margin	64.80%
Operating Margin	-42.33%
Pretax Margin	-44.57%
Profit Margin	-44.04%
EBITDA Margin	-35.52%
EBIT Margin	-42.33%
FCF Margin	n/a

Dividends & Yields

Optomed Oyj does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.57%
Shareholder Yield	-13.57%
Earnings Yield	-7.87%
FCF Yield	-3.29%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Optomed Oyj has an Altman Z-Score of 5.13.

Altman Z-Score	5.13
Piotroski F-Score	n/a